FOXO4-DRI (Proxofim)
FOXO4-DRI (Proxofim) is a synthetic peptide studied for its ability to target senescent cells by disrupting FOXO4–p53 interactions. In preclinical research, this mechanism has been associated with selective apoptosis of senescent cells while preserving healthy cellular populations. FOXO4-DRI is primarily investigated in cellular aging, senescence biology, and longevity-related research contexts. Formulated for research use only.
